Latest Cancer News

Maintenance Rituxan® Is Safe for Follicular Lymphoma (07/03/2008)
Continued treatment for up to two years with Rituxan® (rituximab) is a safe therapeutic approach for the treatment of follicular lymphoma

Motesanib Diphosphate Provides Anticancer Activity Among Patients with Progressive Thyroid Cancer (07/03/2008)
The investigative agent motesanib diphosphate (AMG 706) produces a regression of cancer among patients with thyroid cancer that is progressing despite standard therapies

LYN Kinase Affects Sensitivity to Gleevec® in Chronic Myeloid Leukemia (07/01/2008)
A protein structure known as the LYN kinase appears to play an important role in the effectiveness of Gleevec® (imatinib mesylate) in chronic myeloid leukemia (CML) cancer cells

More Cancer News

Locations

Office Location
9229 Wilshire Blvd.
Beverly Hills, CA 90210
Phone: (310) 205-5777
Fax: (310) 888-8794
Introducing RapidArc.

A new cancer treatment with revolutionary speed and precision